About Mumbai Citiclinic Private Limited
Data last updated:
Mumbai Citiclinic Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 23 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85120MH2006PTC162808.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.88 Lakh. It was formerly known as Avon Medical Centre Private Limited. It is led by directors including Atul Ramniklal Mashru and Puneet Atul Mashru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.98 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹7.11 Cr (net margin 41.9%) and EBITDA of ₹9.49 Cr (EBITDA margin 55.9%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹37.8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mumbaiciticlinic.com.
Company details
Contact details
Mumbai Citiclinic Private Limited's registered office is in Mumbai, Maharashtra. Its website is mumbaiciticlinic.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address802 8 A – 1 1 Summer Trinity New Prabhadevi Road Nagusayajiwadi Pab, Hadevi, Mumbai, Maharashtra, India – 400025
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Mumbai Citiclinic Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mumbai Citiclinic is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Mumbai Citiclinic Private Limited, buy the company report.
Financials of Mumbai Citiclinic Private Limited
FY 2025 filings availableMumbai Citiclinic Private Limited reported revenue of ₹16.98 Cr (up 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 81% growth in the latest year. EBITDA rose 231% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 55.9% | ||||
| Net Profit Margin | 41.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mumbai Citiclinic Private Limited, buy the company report.
Board of directors of Mumbai Citiclinic Private Limited
Mumbai Citiclinic has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Ramniklal Mashru | Director | 06 Jul 2021 | 5 Years 3 Months | Current |
| Puneet Atul Mashru | Director | 16 Jul 2008 | 18 Years 3 Months | Current |
| Kashmira Atul Mashru | Director | 23 Jun 2006 | 20 Years 4 Months | Current |
| Nikita Puneet Mashru | Director | 06 Aug 2016 | 10 Years 2 Months | Current |
Auditor
Mumbai Citiclinic Private Limited is audited by SANGHAVI & KAPADIA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANGHAVI & KAPADIA | FY 2023 | 109100W |
Shareholding
The shareholding of Mumbai Citiclinic Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mumbai Citiclinic Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Apr 2018 | 100180356 | Others | ₹8.78 Lakh | Open | |
| 01 Sep 2016 | 100052235 | Others | ₹5.27 Lakh | Open | |
| 02 Jul 2008 | 10116778 | Icici Bank Limited | ₹12.75 Lakh | Open | |
| 30 Nov 2007 | 10086472 | Icici Bank Limited | ₹11 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Mumbai Citiclinic Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mumbai Citiclinic Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mumbai Citiclinic Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mumbai Citiclinic Private Limited has 7 board changes on record since 2006: 4 appointments and 3 cessations. The latest: Atul Ramniklal Mashru ceased to be Additional Director on 30 Nov 2021.
2 earlier events are in the company report.
Frequently asked questions
Mumbai Citiclinic is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 23 June 2006 (20+ years old) and is registered under CIN U85120MH2006PTC162808.
Mumbai Citiclinic has 4 current directors:
- Atul Ramniklal Mashru - Director
- Puneet Atul Mashru - Director
- Kashmira Atul Mashru - Director
- Nikita Puneet Mashru - Director
The latest financial statements of Mumbai Citiclinic on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mumbai Citiclinic is U85120MH2006PTC162808. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mumbai Citiclinic was incorporated on 23 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Atul Ramniklal Mashru ceased to be Additional Director on 30 Nov 2021. Atul Ramniklal Mashru was appointed as Director on 06 Jul 2021. Jayshree Mayank Mashru ceased to be Director on 06 Aug 2016. Mumbai Citiclinic has 7 board changes on record in total.
Mumbai Citiclinic can be reached through the website mumbaiciticlinic.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mumbai Citiclinic is at 802 8 A – 1 1 Summer Trinity New Prabhadevi Road Nagusayajiwadi Pab, Hadevi, Mumbai, Maharashtra, India – 400025.
Mumbai Citiclinic operates in the healthcare industry, in the preventive health services segment.
Mumbai Citiclinic has open charges of ₹37.8 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
